Cart
sales@molnova.com
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
CAS No. 146504-07-6
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )
Catalog No. M18038 CAS No. 146504-07-6
Cyclohexanediamine has a potential of anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclohexanediamine has a potential of anticancer activity.
-
DescriptionCyclohexanediamine has a potential of anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146504-07-6
-
Formula Weight214.31
-
Molecular FormulaC11H22N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AZD-3759
A potent, oral active, BBB-penetrating EGFR inhibitor (IC50=7.2 nM, L858R pEGFR).
-
Lapatinib ditosylate...
Lapatinib ditosylate is an anti-Y drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung Y.
-
Intetumumab
Intetumumab (CNTO 95) is a fully human anti-α(v)-integrin monoclonal antibody that is a radiosensitizer in xenograft tumor-bearing mice, inhibits tumor growth, and reduces lung metastases in the A549 NSCLC xenograft model.
